Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | Future of CAR-T

Wendy Osborne • 2 Jun 2020
EHA 2020
Diffuse Large B-Cell Lymphoma Lymphoma CAR-T

Wendy Osborne, MBBS (Hons), MRCP, FRCPath, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK, provides an outlook on the current CAR-T climate and where things may move in the future. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Wendy Osborne

2:03
Novel treatment approaches for early-stage DLBCL
Wendy Osborne • 24 Apr 2023
1:20
Improving patient outcomes in CTCL: clinical collaboration and novel agents
Wendy Osborne • 24 Apr 2023
2:19
Session highlights: autoSCT in T-cell lymphoma, classification updates and fertility preservation
Wendy Osborne • 24 Apr 2023
1:01
Pitfalls in the diagnosis of lymphoid malignancies: interpreting PET scans
Wendy Osborne • 24 Apr 2023

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals